-
Cost-Effectiveness Analysis of Tripalimumab for Metastatic or Recurrent Triple-Negative Breast Cancer in Japan
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study
Mar 10, 2025, 14:00 PM -
Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
The Role of Real-World Evidence in Breast Cancer Drug Submissions to NICE: Insights and Challenges
Mar 10, 2025, 14:00 PM -
Cost per Response Analysis of Deucravacitinib and Biologic Treatments for Moderate to Severe Plaque Psoriasis From the Perspective of the Brazilian Private Healthcare System
Mar 10, 2025, 14:00 PM -
Revascularization and Patency in Lower Limb Peripheral Arterial Disease: A Systematic Review and Meta-Analysis Comparing Paclitaxel-Eluting with Bare Metal Stents
Mar 10, 2025, 14:00 PM -
Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Mar 10, 2025, 14:00 PM -
Dinutuximab BetaVersus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma - Matching-Adjusted Indirect Treatment Comparison and Economic Evaluation in Mexico
Mar 10, 2025, 14:00 PM -
Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective
Mar 10, 2025, 14:00 PM -
Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
Mar 10, 2025, 14:00 PM -
Association between Socioeconomic Factors and Guideline-Directed Medical Therapy (GDMT) Utilization Among Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction (HFrEF)
Mar 10, 2025, 14:00 PM -
Economic Burden of Lung Cancer from the Perspective of a Brazilian Public Hospital
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients
Mar 10, 2025, 14:00 PM -
Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Mar 10, 2025, 14:00 PM -
Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications
Mar 10, 2025, 14:00 PM -
Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval
Mar 10, 2025, 14:00 PM -
Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China
Mar 10, 2025, 14:00 PM
